A Deadly Outbreak of Plague, Nearly 5,000 Years Before the Black Death

NYT Science Wednesday 17 June 2026, 15:00 UTC By Carl Zimmer 1 min read

Key Points

The oldest known cases, discovered among hunter-gatherers in Siberian graves, contradict the theory that the disease once was mild.

Siberian (ORG)

Originally published by NYT Science Read original →

The Centre has raised the ceiling prices of BCG, Measles and Measles-Rubella (MR) vaccines by about 21% after reconsidering an earlier pricing order following a review application by Serum Institute of India. In a gazette notification, the National Pharmaceutical Pricing Authority (NPPA) increased the ceiling price of BCG vaccine from ₹8.20 to ₹9.89 per dose, Measles vaccine from Rs 51.40 to Rs 62 per vial and Measles-Rubella vaccine from ₹72.90 to ₹87.93 per vial. The revision stems from a...

Times of India 23m ago

Nurse struck off for telling cancer patient Covid vaccine caused their illness

Nurse struck off for telling cancer patient Covid vaccine caused their illness Penny Ann Senner was employed as an adult nurse at Dorset Healthcare University NHS Foundation Trust when she made the comments, a Nursing and Midwifery Council (NMC) misconduct panel ruled - Bookmark - CommentsGo to comments A nurse who told a patient Covid vaccinations were “what caused your cancer” has been struck off the nursing register. Penny Ann Senner was employed as an adult nurse at Dorset Healthcare...

The Independent UK 28m ago

Why are experts warning latest Ebola outbreak could be ‘worst ever’?

Why are experts warning latest Ebola outbreak could be ‘worst ever’? The virus is spreading faster than health workers can track it and international funding has slumped. The deadly Ebola virus outbreak in eastern Africa could be the “worst ever” in history, the director-general of Africa’s Centres for Disease Control and Prevention, Jean Kaseya, has warned.

Al Jazeera 37m ago

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

UniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the company said Wednesday, months after previous agency leaders criticized the evidence backing the application. UniQure said the FDA in a recent meeting communicated that a three-year analysis from a Phase 1/2 study would support an accelerated approval of UniQure's gene therapy for Huntington's, a rare hereditary disease that gradually destroys nerve cells in the brain. As a result of the...

CNBC 40m ago

A Deadly Outbreak of Plague, Nearly 5,000 Years Before the Black Death

Related Stories

Govt raises ceiling prices of BCG, Measles vaccines by 21%

Nurse struck off for telling cancer patient Covid vaccine caused their illness

Why are experts warning latest Ebola outbreak could be ‘worst ever’?

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency